Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Garcia

Showing results (421-430 of 455) with videos related to

Pageof 46
Sort By:
JAMA Cardiology|June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical TrialGregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
Circulation|September 26, 2022
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited CardiomyopathyAmrit S Lota, Mark R Hazebroek, Pantazis Theotokis, et al.
The New England Journal of Medicine|August 30, 2024
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, John L Berk, Julian D Gillmore, et al.
European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.
Journal of the American College of Cardiology|October 1, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Nature Medicine|January 8, 2025
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trialPablo Garcia-Manau, Erika Bonacina, Raquel Martin-Alonso, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
European Heart Journal|June 7, 2019
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy RegistryLia Crotti, Carla Spazzolini, David J Tester, et al.
Translational Psychiatry|February 25, 2021
Long runs of homozygosity are associated with Alzheimer's diseaseSonia Moreno-Grau, Maria Victoria Fernández, Itziar de Rojas, et al.
Pageof 46

Showing results (421-430 of 455) with videos related to

Sort By:
Pageof 46
JAMA Cardiology|June 17, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical TrialGregory D Lewis, Pablo Garcia-Pavia, Ahmad Masri, et al.
Circulation|September 26, 2022
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited CardiomyopathyAmrit S Lota, Mark R Hazebroek, Pantazis Theotokis, et al.
The New England Journal of Medicine|August 30, 2024
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, John L Berk, Julian D Gillmore, et al.
European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.
Journal of the American College of Cardiology|October 1, 2024
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Nature Medicine|January 8, 2025
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trialPablo Garcia-Manau, Erika Bonacina, Raquel Martin-Alonso, et al.
JACC. Heart Failure|July 18, 2025
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric StudyMaria Perotto, Alessia Paldino, Francesco Mazzarotto, et al.
European Heart Journal|June 29, 2022
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculatorAlexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto, et al.
European Heart Journal|June 7, 2019
Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy RegistryLia Crotti, Carla Spazzolini, David J Tester, et al.
Translational Psychiatry|February 25, 2021
Long runs of homozygosity are associated with Alzheimer's diseaseSonia Moreno-Grau, Maria Victoria Fernández, Itziar de Rojas, et al.
Pageof 46